S.Africa's Aspen aims to sharply increase COVID-19 vaccine capacity

GQEBERHA, South Africa (Reuters) -South Africa’s Aspen Pharmacare is aiming to ramp up its COVID-19 vaccine manufacturing capacity to 1.3 billion doses a year by February 2024, up from a current annual output of around 250 million doses, the company’s CEO told Reuters on Monday. Read full story

Source : https://www.thestar.com.my/news/world/2021/10/25/safrica039s-aspen-aims-to-sharply-increase-covid-19-vaccine-capacity